[Corrigendum] miR‑135 regulated breast cancer proliferation and epithelial‑mesenchymal transition acts by the Wnt/β‑catenin signaling pathway

Jiang,Daqiong; Zhou,Bo; Xiong,Yan; Cai,Hongbing

doi:10.3892/ijmm.2022.5161

August-2022 Volume 50 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2022 Volume 50 Issue 2

Full Size Image

Correction Open Access

[Corrigendum] miR‑135 regulated breast cancer proliferation and epithelial‑mesenchymal transition acts by the Wnt/β‑catenin signaling pathway

Authors:
- Daqiong Jiang
- Bo Zhou
- Yan Xiong
- Hongbing Cai
View Affiliations / Copyright

Affiliations: Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China

Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 105
|
Published online on: June 20, 2022

https://doi.org/10.3892/ijmm.2022.5161
Expand metrics +

Article

Int J Mol Med 43: [Related article:] 1623-1634, 2019; DOI: 10.3892/ijmm.2019.4081

After the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 2A on p. 1626, the data panels showing the results for the 'Bright/Blank control' and 'Bright/mi-135 inhibitors' experiments appeared to be identical; furthermore, in Fig. 8 on p. 1632, Figs. 8B and D appeared to contain identical data, even though the contrast settings for the two sets of panels were a little different.

Figure 2

miR-135 inhibits cell proliferation. Following transfection with miR-135 mimics or miR-135 inhibitors in (A) MDA-MB-468 and (B) MCF-7 cells, the transfection efficiency was detected by reverse transcription-quantitative polymerase chain reaction. The proliferation of cells was determined by (C) MTT and (D) colony formation assay. The results were expressed as the mean ± standard deviation of three independent experiments. *P<0.05 and **P<0.01 vs. control group. #P<0.05 and ##P<0.01 vs. NC group. NC, negative control; miR, microRNA; OD, optical density; GFP, green fluorescent protein.

Figure 8

miR-135 inhibits the epithelial-mesenchymal transition which is associated with the activation of Wnt/β-catenin signaling. Immunofluorescence analysis of the alterations in the expression of (A) Wnt, (B) p-GSK3, (C) GSK3 and (D) β-catenin in MCF-7 cells. NC, negative control; miR, microRNA; p-GSK, phosphorylated glycogen synthase kinase.

The authors have re-examined their original data, and regret that Figs. 2 and 8 were inadvertently both assembled incorrectly, as identified by the external reader. However, the authors retained their original data, and were able to reassemble both these figures correctly. The revised versions of Figs. 2 and 8 are shown on the next two pages, now including the correct data for the 'Bright/Blank control' experiment in Fig. 2A and the correct immunofluorescence data in Fig. 8B. Note that the revised data shown for these figures do not affect the overall conclusions reported in the paper. The authors express their gratitude to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] miR‑135 regulated breast cancer proliferation and epithelial‑mesenchymal transition acts by the Wnt/β‑catenin signaling pathway

This article is mentioned in:

Article

Figure 2

Figure 8

Related Articles